heptelidic acid has been researched along with etoposide in 1 studies
Studies (heptelidic acid) | Trials (heptelidic acid) | Recent Studies (post-2010) (heptelidic acid) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
---|---|---|---|---|---|
34 | 0 | 15 | 18,306 | 3,693 | 4,900 |
Protein | Taxonomy | heptelidic acid (IC50) | etoposide (IC50) |
---|---|---|---|
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
Caspase-3 | Homo sapiens (human) | 1 | |
DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, JH; Lee, CH | 1 |
1 other study(ies) available for heptelidic acid and etoposide
Article | Year |
---|---|
Heptelidic acid, a sesquiterpene lactone, inhibits Etoposide-induced apoptosis in human leukemia U937 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Etoposide; Humans; Neurodegenerative Diseases; Sesquiterpenes; Trichoderma; U937 Cells | 2009 |